Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trialArlene O. Siefker‐Radtke, Wei Xue, Earle F. Burgess et al.|Annals of Oncology|2023Cited by 82
Long-term oncologic outcomes of robot-assisted radical cystectomy: update series from a high-volume robotic center beyond 10 years of follow-upCarlo Andrea Bravi, Alexandre Mottrie, Pietro Piazza et al.|Journal of Robotic Surgery|2022Cited by 9